Nijmegen-Bethesda Assay to Measure Factor VIII Inhibitors
- 27 February 2013
- book chapter
- research article
- Published by Springer Science and Business Media LLC in Methods in Molecular Biology
- Vol. 992, 321-333
- https://doi.org/10.1007/978-1-62703-339-8_24
Abstract
Hemophilia A is an inherited bleeding disorder caused by a deficiency of factor VIII coagulant activity (FVIII:C). Patients are treated with infusions of either plasma-derived or recombinant factor VIII. However, some patients develop inhibitory antibodies (inhibitors) to infused factor VIII which render it ineffective. The original Bethesda method was developed to standardize measurement of inhibitors in a factor VIII neutralization assay. One Bethesda unit is defined as that amount of inhibitor that results in 50% residual FVIII:C activity of a defined test mixture. In the Nijmegen modification of the original Bethesda method, the pH and the protein concentration of the test mixture is further standardized. As a result, the FVIII:C in the test mixture is less prone to artifactual deterioration and the test has improved specificity. Even with a standardized procedure a number of factors can affect the performance of the test and it is important for laboratory staff to be aware of their impact on the result outcome.Keywords
This publication has 31 references indexed in Scilit:
- Inhibitor treatment in haemophilias A and B: inhibitor diagnosisHaemophilia, 2006
- Epidemiology of inhibitor formation with recombinant factor VIII replacement therapyHaemophilia, 2006
- Neutralization of antifactor VIII inhibitors by recombinant porcine factor VIIIJournal of Thrombosis and Haemostasis, 2006
- The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors OrganisationBritish Journal of Haematology, 2006
- Identification of factor inhibitors by diagnostic haemostasis laboratoriesThrombosis and Haemostasis, 2006
- Effect of Activated Recombinant Human Factor 7 (Niastase) on Laboratory Testing of Inhibitors of Factors VIII and IXLaboratory Hematology, 2005
- A simple inhibitor screen is more sensitive than a Bethesda assay in monitoring for the development of inhibitors in haemophilia A and BBritish Journal of Haematology, 2005
- Factor V inhibitorsBlood Coagulation & Fibrinolysis, 2004
- Inter‐laboratory variability of the measurement of low titer factor VIII:C inhibitor in haemophiliacs: improvement by the Nijmegen modification of the Bethesda assay and the use of common lyophilized plasmasHaemophilia, 1999
- Incidence of inhibitors in haemophiliacs. A review of the literatureBlood Coagulation & Fibrinolysis, 1993